Potassium clavulanate cellulose

Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Clavulanate potassium is a form of Clavulanic acid. Clavulanate potassium fights bacteria that resistant to penicillins and other antibiotics. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin^[1][2]. In Vitro:Clavulanate potassium (2 μg/mL) is susceptive to β-lactamase-positive and β-lactamase-negative Bacteroides spp. and Fusobacterium spp. with the combination of amoxicillin (4 μg/mL) and ticarcillin (64 μg/mL)^[1].
Clavulanate potassium (16 μg/mL) inhibits B. intermedius, B. bivius, B. disiens, B. oris, B. buccae, B. buccalis and B. loeschei with MIC₅₀ values of 8 μg/mL^[1].
Clavulanate potassium (16 μg/mL) inhibits B. melaninogenicus, B. oralis and F. varium with MIC₅₀ values of 16 μg/mL^[1].
Clavulanate potassium (2 μg/mL) raises amoxicillin susceptibility rates for β-lactamase-positive Bacteroides species and fusobacteria from 41.3 to 90.8% and from 64.2 to 88.7%, respectively^[1]. In Vivo:Clavulanate potassium (125 mg; 20 d) protects 75% of mice with experimental pneumonitis compared with no survivors in the control group^[2].